Profile picture

Doctor Marine Sargsyan

Yerevan State Medical University after M. Heratsi, Yerevan (Armenia)
Follow
Biography
Marine Sargsyan is currently studying Cardiology residency at Erebouni Medical Center through Yerevan State Medical University, where she earned her Bachelor's Degree. She is also pursuing an online Master of Science in Preventative Cardiovascular Medicine at the University of South Wales. Marine is passionate about helping people, treating patients, and doing scientific work to improve heart health and prevent disease. During the COVID-19 pandemic, she worked as a Doctor's Assistant at the National Center for Infectious Diseases through a contract and as a volunteer. She also did internships at several clinics affiliated with YSMU, where she gained experience in patient care and communication. Her main interests include heart disease prevention and combining research with clinical work. Marine speaks Armenian (native), English (intermediate), Russian (intermediate), and Chinese (A2 level). She enjoys playing chess and reading medical, philosophical, and biographical fiction.
Logo ESC

Contributor content

Armenian national registry of myocardial infarction (ARMI): first results from a nationwide prospective stemi registry
Presentation
Armenian national registry of myocardial infarction (ARMI): first results from a nationwide prospective stemi registry
Percutaneous treatment for acute and chronic coronary syndromes: presentation of the situation in the EuroAsia region
Presentation
Percutaneous treatment for acute and chronic coronary syndromes: presentation of the situation in the EuroAsia region
Efficacy of guideline-based management and recurrence risk in peripartum cardiomyopathy: a multicenter cohort analysis
Presentation
Efficacy of guideline-based management and recurrence risk in peripartum cardiomyopathy: a multicenter cohort analysis
Efficacy and safety of dapagliflozin in non-diabetic patients with primary anterior ST-elevation myocardial infarction initiated  in early hospital period
Presentation
Efficacy and safety of dapagliflozin in non-diabetic patients with primary anterior ST-elevation myocardial infarction initiated in early hospital period

ESC 365 is supported by